Global Biomarker Clinical Phase Outsourcing Services Market Size, Share, and COVID-19 Impact Analysis, By Biomarker Type (Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, and Others), By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, and Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare

RELEASE DATE Jun 2024
REPORT ID SI4592
PAGES 220
REPORT FORMAT PathSoft

Request Free Sample

Your personal details will remain secure and confidential - Privacy Policy

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies